Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akifumi Mochizuki

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Journal of Gastroenterology|May 2, 2026
A case of immune-mediated adverse events enterocolitis and duodenitis with gastrointestinal bleeding successfully treated with ustekinumabRyo Morikawa, Yuka Hachisu, Toshimitsu Fujii, et al.
Cancer Treatment and Research Communications|September 3, 2023
Evaluating the potential of immunotherapy and chemoimmunotherapy in the treatment of elderly non-small cell lung cancer patients: A real-world studySatoshi Endo, Takayuki Honda, Kazuaki Sato, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 21, 2024
Passive Smoking-Induced Mutagenesis as a Promoter of Lung CarcinogenesisAkifumi Mochizuki, Kouya Shiraishi, Takayuki Honda, et al.
Nature Communications|August 17, 2023
An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stressTaichi Igarashi, Marianne Mazevet, Takaaki Yasuhara, et al.
ERJ Open Research|February 26, 2025
A strong association between TTF-1 expression and interstitial lung disease in predicting the efficacy of PD-1 inhibitor for nonsquamous NSCLC patientsMasaru Ito, Takayuki Honda, Iichiroh Onishi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2025
Chromosome 15q15 Deletion Drives Brain Metastasis in NSCLCJun Miyakoshi, Kouya Shiraishi, Akifumi Mochizuki, et al.
Lung Cancer (Amsterdam, Netherlands)|April 2, 2021
Non-inferior clinical outcomes of immune checkpoint inhibitors in non-small cell lung cancer patients with interstitial lung diseaseYuri Tasaka, Takayuki Honda, Naoki Nishiyama, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2025
Implications of EGFR expression on EGFR signaling dependency and adaptive immunity against EGFR-mutated lung adenocarcinomaMasahiro Torasawa, Tatsuya Yoshida, Kouya Shiraishi, et al.
Nature Communications|November 6, 2025
Mutation of CMTR2 in Lung Adenocarcinoma Alters RNA Alternative Splicing and Reveals Therapeutic VulnerabilitiesShigenari Nukaga, Kouya Shiraishi, Kenta Hamabe, et al.
NPJ Breast Cancer|November 29, 2025
Germline variants of the POLH and RAD51 genes are candidate variants associated with risk of hormone receptor-negative young-onset breast cancerShu Yazaki, Rui Kitadai, Yukihide Momozawa, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Journal of Gastroenterology|May 2, 2026
A case of immune-mediated adverse events enterocolitis and duodenitis with gastrointestinal bleeding successfully treated with ustekinumabRyo Morikawa, Yuka Hachisu, Toshimitsu Fujii, et al.
Cancer Treatment and Research Communications|September 3, 2023
Evaluating the potential of immunotherapy and chemoimmunotherapy in the treatment of elderly non-small cell lung cancer patients: A real-world studySatoshi Endo, Takayuki Honda, Kazuaki Sato, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 21, 2024
Passive Smoking-Induced Mutagenesis as a Promoter of Lung CarcinogenesisAkifumi Mochizuki, Kouya Shiraishi, Takayuki Honda, et al.
Nature Communications|August 17, 2023
An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stressTaichi Igarashi, Marianne Mazevet, Takaaki Yasuhara, et al.
ERJ Open Research|February 26, 2025
A strong association between TTF-1 expression and interstitial lung disease in predicting the efficacy of PD-1 inhibitor for nonsquamous NSCLC patientsMasaru Ito, Takayuki Honda, Iichiroh Onishi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2025
Chromosome 15q15 Deletion Drives Brain Metastasis in NSCLCJun Miyakoshi, Kouya Shiraishi, Akifumi Mochizuki, et al.
Lung Cancer (Amsterdam, Netherlands)|April 2, 2021
Non-inferior clinical outcomes of immune checkpoint inhibitors in non-small cell lung cancer patients with interstitial lung diseaseYuri Tasaka, Takayuki Honda, Naoki Nishiyama, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2025
Implications of EGFR expression on EGFR signaling dependency and adaptive immunity against EGFR-mutated lung adenocarcinomaMasahiro Torasawa, Tatsuya Yoshida, Kouya Shiraishi, et al.
Nature Communications|November 6, 2025
Mutation of CMTR2 in Lung Adenocarcinoma Alters RNA Alternative Splicing and Reveals Therapeutic VulnerabilitiesShigenari Nukaga, Kouya Shiraishi, Kenta Hamabe, et al.
NPJ Breast Cancer|November 29, 2025
Germline variants of the POLH and RAD51 genes are candidate variants associated with risk of hormone receptor-negative young-onset breast cancerShu Yazaki, Rui Kitadai, Yukihide Momozawa, et al.
Pageof 2